GENE ONLINE|News &
Opinion
Blog

2026-02-03|

Match Group Reports $850 Million Revenue in Q4 2025 with 6% Year-Over-Year Growth

by GOAI
Share To

Match Group has released its financial results for the fourth quarter and full year ending December 31, 2025. The company reported key performance metrics, including revenue figures, operating income, and user engagement statistics across its portfolio of dating platforms.

In the fourth quarter of 2025, Match Group recorded total revenue of $850 million, reflecting a year-over-year increase of 6%. Operating income for the same period reached $300 million, representing a growth of 8% compared to the prior year’s fourth quarter. For the full year, Match Group’s total revenue amounted to $3.2 billion, with an annual operating income of $1.1 billion. The company also highlighted a rise in paying users across its platforms, which include Tinder, Hinge, and other dating services. Additionally, Match Group noted improvements in user retention rates and engagement levels during the reporting periods. Further details on regional performance and platform-specific metrics were not disclosed in this announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ambarella to Present The Ambarella Edge Initiative on Physical AI at Embedded World 2026
2026-02-09
GXO Logistics to Manage Operations at BMW Group’s Swindon Site
2026-02-09
Trip.com Group Limited to Release Q4 and Full-Year 2025 Financial Results on February 25, 2026
2026-02-09
FireFox Gold Reports 54.91 g/t Gold Over 1.95 Meters in Northeast Zone Expansion at Mustajärvi Project
2026-02-09
TotalEnergies to Supply Google with 1 GW of Solar Energy for Texas Data Centers Over 15 Years
2026-02-09
TrumpRx Enters Pharmaceutical Market as Novo Nordisk Plans Super Bowl Ad for Oral Wegovy
2026-02-09
VHH Antibodies Derived from Camelids Show Potential for Targeted Therapies Despite Stability Challenges
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top